Verona, September 27, 2018 – The Macrophage and Dendritic Cell Society is holding its 32nd annual meeting 27-29 September in beautiful Verona, Italy. This year’s theme is “the crossroad between macrophage and dendritic cells: from immunometabolism to single cell fate.” In this context, TRON’s Mustafa Diken is giving today’s Happy Hour Lecture, entitled “Bringing the message to dendritic cells with mRNA.”
Mainz, September 2018 - TRON is proudly hosting a scholar from the Zoran Djindjic Program (ZDS). Created in 2003 after the assassination of the first democratically elected Prime Minister of Serbia, and supported by the German federal government, the aim of the program is to provide short internships in German institutions for highly qualified candidates from the West Balkans (Albania, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, Croatia and Serbia). TRON’s student, Marijana Slijepčević, has written a blog about her ZDS experiences, which we invite you to read here.
Mainz, September 2018 - TRON is sponsoring two scholarships in the Deutschlandstipendium 2018/2019 of the Johannes Gutenberg University Mainz, thereby supporting two young medical students as part of this Federal Ministry of Education and Research program. Scholarship holders were selected based on proven excellence, exceptional social commitment, and special social or family circumstances.
Mainz, September 7, 2018 – TRON is thrilled to announce an article co-authored by Mustafa Diken and Lina Hilscher in the journal EJNMMI Research (European Journal of Nuclear Medicine and Molecular Imaging Research).
In collaboration with Dr. Matthias Miederer’s group in the Department of Nuclear Medicine at the University Medical Center Mainz, TRON scientists contributed in showing that FDG-PET can be used for in vivo imaging of the immune response to systemic RNA vaccination. The article describes rapid and transient vaccination-induced increase of FDG uptake within the spleen, reflecting immune activation preceding T-cell proliferation. This finding shows the potential of FDG-PET/CT as a new application to image immune processes in the search for new therapies.
You can read the article here.
Mainz, September 6, 2018 - The University Cancer Center at the University Mainz is host to their 1st Science Day 2018 on September 6th 2018. The event features a variety of young investigators and established scientists presenting their research in the fields of cancer immunotherapy, genetic instability, epidemiology, or drug delivery.
Our doctoral student Nadja Salomon will present her combination therapy studies using local radiotherapy and E7-RNA-LPX vaccination. She will give a talk during the session "Tumor Immunology/Cancer Immunotherapy" at 9:40 a.m.. At 3:20 p.m., Mustafa Diken will give his talk "Delivering the Messenger for Cancer Immunity" in the session "Drug delivery".
The programm concludes with a lecture by Prof. Dr. Margret Shipp from the Harvard Medical School and Dana Faber Cancer Center in Boston, USA, as part of the Mildred Scheel Lecture series. The Keynote Lecture entitled "Targetable Genetic Signatures in Lymphoid Malignancies" will start 4:30 p.m..
Mainz, August 22, 2018 - The Center for Thrombosis and Hemostasis (CTH) at the University Medical Center Mainz is host to a new Innovative Training Network (ITN) „TICARDIO – Thrombo-Inflammation in Cardiovascular Disease“. It will address the studies of pathological processes in cardiovascular diseases. The ITN offers 15 science graduate students the opportunity to develop scientific and general skills within a cross-border network. The structured international, interdisciplinary, and intersectoral research and training program will take place from 2019 at Mainz, Maastricht, Marseille, and Dortmund. The European Commission is providing 4 million euros to ITN under the Marie Skłodowska Curie Action (MSCA) for 48 months through its Horizon 2020 Framework Program for Research and Innovation. As part of the doctoral training program, TRON participates as an external institution in which the doctoral students can gain non-academic experience.
Further information can be found in the official press release.
TRON in the Media
Welcome to TRON
TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz is a biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with high medical need. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating basic research into drug applications. TRON partners with academic institutions, biotech companies and the pharmaceutical industry, executing research with leading-edge technologies and supporting the development of innovative drugs to promote human health.